Fibroblast growth factor-like polypeptides

Details Fibroblast growth factor-like polypeptides Fibroblast growth factor-like polypeptides

1999-09-07

2008-08-05

Wehbe, Anne Marie S. (Department: 1633)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C435S070100, C435S320100, C435S325000

Reexamination Certificate

active

07408047

ABSTRACT:
The present invention provides novel Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing FGF-like polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with FGF-like polypeptides.

REFERENCES:
patent: 3773919 (1973-11-01), Boswell et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 4945050 (1990-07-01), Sanford et al.
patent: 4970154 (1990-11-01), Chang
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5106627 (1992-04-01), Aebischer et al.
patent: 5217889 (1993-06-01), Roninson et al.
patent: 5234784 (1993-08-01), Aslam et al.
patent: 5252714 (1993-10-01), Harris et al.
patent: 5272071 (1993-12-01), Chappel
patent: 5364791 (1994-11-01), Vegeto et al.
patent: 5489743 (1996-02-01), Robinson et al.
patent: 5557032 (1996-09-01), Mak
patent: 5589362 (1996-12-01), Bujard et al.
patent: 5593875 (1997-01-01), Wurm et al.
patent: 5635399 (1997-06-01), Kriegler et al.
patent: 5650298 (1997-07-01), Bujard et al.
patent: 5654168 (1997-08-01), Bujard et al.
patent: 5672510 (1997-09-01), Eglitis et al.
patent: 5676954 (1997-10-01), Brigham
patent: 5679559 (1997-10-01), Kim et al.
patent: 5811234 (1998-09-01), Roninson et al.
patent: 6150098 (2000-11-01), Zhang et al.
patent: 6639063 (2003-10-01), Edwards et al.
patent: 6716626 (2004-04-01), Itoh et al.
patent: 7259248 (2007-08-01), Itoh et al.
patent: 2001/0012628 (2001-08-01), Agarwal et al.
patent: 2007/0128619 (2007-06-01), Itoh et al.
patent: 2007/0238657 (2007-10-01), Itoh et al.
patent: 0036676 (1981-09-01), None
patent: 0058481 (1982-08-01), None
patent: 0088046 (1983-09-01), None
patent: 133988 (1985-03-01), None
patent: 0143949 (1985-06-01), None
patent: 0154316 (1985-09-01), None
patent: 401384 (1990-12-01), None
patent: 0505500 (1992-09-01), None
patent: 91/09955 (1991-07-01), None
patent: 91/10425 (1991-07-01), None
patent: 91/10470 (1991-07-01), None
patent: 93/15722 (1993-08-01), None
patent: 94/20069 (1994-09-01), None
patent: 94/28122 (1994-12-01), None
patent: 95/05452 (1995-02-01), None
patent: 95/34670 (1995-12-01), None
patent: 96/37609 (1996-11-01), None
patent: 96/40958 (1996-12-01), None
patent: 96/41865 (1996-12-01), None
patent: 97/31899 (1997-09-01), None
patent: WO 00/54813 (2000-09-01), None
patent: WO 01/18209 (2001-03-01), None
patent: WO 01/18209 (2001-05-01), None
patent: WO 01/32678 (2001-05-01), None
patent: WO 01/36640 (2001-05-01), None
patent: WO 01/38357 (2001-05-01), None
patent: WO 01/49849 (2001-07-01), None
Branch, A good antisense molecule is hard to find, Feb. 23, 1998, TIBS, pp. 45-50.
Verma et al., Gene therapy-promises,problems and prospects, Sep. 18, 1997, Nature, vol. 389, pp. 239-242.
Ledley, Pharmaceutical Approach to Somatic Gene Therapy, Nov. 1996, Pharmaceutical Research, pp. 1595-1614.
Faham et al., Diversity does make a difference: fibroblast growth factor-heparin interactions, Elsevier Current Trends, 1998, vol. 1998, p. 578-586.
Kennel, D.E., “Principles and practices of nucleic acid hybridization,” Progr. Nucl. Acid Res. Mol. Biol. 11: 259-301, 1971.
GenBank Acc. No. AQ175436, “HS—3207—A1—H09—MR CIT approved human genomic sperm library DHomo sapeinsgenomic clone Plate+3207 Col+17 Row+0, genomic survey sequence,” US Natl. Lib. Med., Bethesda, MD, USA, Oct. 17, 1998, accessed by PTO Nov. 18, 2005.
GenBank Acc. No. AV050323, “AV050323 Mus musculus pancreas C57BL/6J adult Mus musculus clone 1810013H18, mRNA sequence,” US Natl. Med., Bethesda, MD, USA, Jun. 22, 1999, accessed by PTO Nov. 18, 2005.
Goldfarb, M., “Functions of fibroblast growth factors in vertebrate development,” Cytokine & Growth Factor Rev. 7(4): 311-325, 1996.
Hu et al., “FGF-18, a novel member of the fibroblast growth factor family, stimulates hepatic and intestinal proliferation,” Mol. Cell. Biol. 18(10): 6063-6074, Oct. 1998.
The ADHR Consortium. “Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.”Nature Genetics.26:345-348 (2000).
Econs and McEnery. “Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder.”J Clin Endocrinol Metab82:674-681 (1997).
Nishimura et al., “Identification of a novel FGF, FGF-21, preferentially expressed in the liver(1).”Biochim Biophys Acta21:203-6 (2000).
Ghielli et al. “Regeneration processes in the kidney after acute injury: role of infiltrating cells.”Exp Nephrol6:502-7 (1998).
Webster. “Growth factors and myelin regeneration in multiple sclerosis.”Mult Scler3:113-20 (1997).
Ratajczak. “Fibroblast growth factors and early hemopoietic cell development.”Leuk Lymphoma27:221-9 (1997).
Yamaoka and Itakura. Development of pancreatic islets (review).Int J Mol Med3:247-61 (1999).
Hoppenreijs et al. “Corneal endothelium and growth factors.”Surv Ophthalmol41:155-64 (1996).
Kornmann et al. “Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis.”Pancreas17:169-75 (1998).
Peus and Pittelkow. “Growth factors in hair organ development and the hair growth cycle.”Dermatol Clin14:559-72 (1996).
Artuc et al. “Mast cells and their mediators in cutaneous wound healing—active participants or innocent bystanders?”Exp Dermatol8:1-16 (1999).
Ebadi et al. “Neurotrophins and their receptors in nerve injury and repair.”Neurochem Int30:347-74 (1997).
Cunha et al. “Keratinocyte growth factor as mediator of mesenchymal-epithelial interactions in the development of androgen target organs.”Semin Cell Dev Biol7:203-210 (1996).
Galzie et al. “Fibroblast growth factors and their receptors.”Biochem Cell Biol75:669-85 (1997).
Lewis et al. “Angiogenesis by gene therapy: a new horizon for myocardial revascularization?”Cardiovasc Res35:490-7 (1997).
Podolsky. “Healing the epithelium: solving the problem from two sides.”J Gastroenterol32:122-6 (1997).
Beck and Podolsky. “Growth factors in inflammatory bowel disease.”Inflamm Bowel Dis5:44-60 (1999).
GenBank, Accession No. BAA99415, Aug. 2000.
GenBank, Accession No. NP—061986, Nov. 2000.
GenBank, Accession No. Q9NSA1, Oct. 2000.
Accession No. AB006136, Aug. 27, 1997, XP002165898.
Accession No. AQ175436, Sep. 21, 1998, XP002188227.
Accession No. AV050323, Jun. 16, 1999, XP002165897.
Galzie Z. et al., “Fibroblast Growth Factors and their Receptors”, Biochemistry and Cell Biology, vol. 75, No. 6, 1997, pp. 669-685.
Smallwood P.M. et al., “Fibroblast Growth Factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development”, Proceedings of the National Academy of Sciences of the USA, vol. 93, Sep. 1996 pp. 9850-9857.
Hull et al, “Healing with basic fibroblast growth factor is associated with reduced indomethacin induced relapse in a human model of gastric ulceration,” Gut, 40:204-10 (1997).
Hsu et al., “Heparin Is Essential for a Single Keratinoctye Growth Factor Molecule To Bind and Form a Complex with Two Molecules of the Extracellular Domain of Its Receptor,” Biochemistry, 38:2523-34 (1999).
Plotnikov et al., “Crystal Structures of Two FGF-FGFR Complexes Reveal the Determinants of Ligand-Receptor Specificity,” Cell 101:413-24 (2000).
Doerks et al., “Protein annotation: detective work for function prediction,” Trends Genet. 14(6):248-50 (1998).
Mikkelsen, “Interpreting sequence motifs: a cautionary note,” Trends Genet. 95(5):159 (1993).
Nakamura et al., “The Murine lymphotoxin-beta receptor cDNA: isolation by the signal sequence trap and ch

Affiliated with

Also associated with

Rating

Fibroblast growth factor-like polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fibroblast growth factor-like polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibroblast growth factor-like polypeptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3998835